Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

This study has been completed.
Information provided by:
Medicure Identifier:
First received: November 20, 2006
Last updated: November 15, 2007
Last verified: November 2007